Skip to main content
. 2017 Aug 21;56(18):2395–2399. doi: 10.2169/internalmedicine.8520-16

Table 1.

Patients Profile.

All No iron Oral iron
No 125 83 42
Age (year), male/female 66±13, 86/39 67±13, 56/27 64±14, 24/18
Duration of HD (years) 10±10 10±10 10±8
Original disease* 48/49/10/9/9 34/29/5/7/8 14/20/5/2/1
Hb (g/L) 10.4±1.3 10.9±1.2 9.3±0.7
Fe (μg/dL) 74±33 81±35 58±27
TIBC (μg/dL) 277±54 276±54 278±55
TSAT (%) 28±14 31±15 22±10
Ferritin (ng/mL) 76±127 94±151 38±37
Cr (mg/dL) 9.2±2.3 9.2±2.5 9.3±2.0
BUN (mg/dL) 53±11 54±11 52±12
Ca (mg/dL) 9.2±0.6 9.2±0.7 9.1±0.6
P (mg/dL) 5.1±1.1 5.0±1.0 5.3±1.1
Alb (g/dL) 3.8±0.4 3.8±0.4 3.7±0.4
AST (IU/L) 13±5 13±5 13±5
ALT (IU/L) 10±7 10±4 11±10
ALP (IU/L) 263±88 266±97 253±69
CRP (mg/dL) 0.32±0.47 0.32±0.44 0.32±0.53

The data are expressed as mean ± standard deviation.

Hb: hemoglobin, Fe: iron, TIBC: total iron binding capacity, TSAT: transferrin saturation, Cr: creatinine, BUN: blood urea nitrogen, Ca: calcium, P: phosphate, Alb: albumin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, CRP: C-reactive protein, HD: hemodialysis, CGN: chronic glomerulonephritis, DM: diabetic nephropathy, HTN: hypertensive nephrosclerosis, PCKD: polycystic kidney disease

*: CGN/DM/HTN/PCKD/Other diseases